Publicaciones en las que colabora con Esteban Orenes Piñero (15)

2023

  1. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    FASEB Journal, Vol. 37, Núm. 6

2016

  1. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

    European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 123-129

  2. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold

    Platelets, Vol. 27, Núm. 8, pp. 777-783

2015

  1. Biomarkers of necrosis and myocardial remodeling

    General Methods in Biomarker Research and their Applications (Springer International Publishing), pp. 659-688

  2. Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state

    Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617

  3. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

    Journal of Internal Medicine, Vol. 278, Núm. 1, pp. 50-58

  4. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

    European Journal of Clinical Investigation, Vol. 45, Núm. 2, pp. 179-186

2014

  1. High-sensitivity troponin t as a biomarker for the development of atrial fibrillation after cardiac surgery

    European Journal of Cardio-thoracic Surgery, Vol. 45, Núm. 4, pp. 733-738

  2. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

    QJM, Vol. 107, Núm. 8, pp. 613-621

2013

  1. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

    PACE - Pacing and Clinical Electrophysiology, Vol. 36, Núm. 1, pp. 31-36

  2. Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

    Annals of Medicine, Vol. 45, Núm. 4, pp. 341-347

  3. Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes

    Atherosclerosis, Vol. 227, Núm. 2, pp. 313-322

2012

  1. High-sensitivity troponin T and Copeptin in Non-ST acute coronary syndromes: Implications for prognosis and role of hsTnT and copeptin in non-STEACS

    TheScientificWorldJournal, Vol. 2012

2011

  1. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy

    Medicinal Chemistry, Vol. 7, Núm. 4, pp. 275-285

  2. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 12, Núm. 4, pp. 521-530